Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Plos One|May 5, 2020
Role of trypsin and protease-activated receptor-2 in ovarian cancerKyu Kwang Kim, Rachael Turner, Negar Khazan, et al.Cell Journal|July 27, 2024
Prognostic Significance of Circulating and Disseminated Tumor Cells in Breast Cancer Patients before and after Adjuvant ChemotherapyParisa Ghaffari, Meysam Yousefi, Mozaffar Aznab, et al.Translational Oncology|May 15, 2019
Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian CancerRachael B Rowswell-Turner, Jennifer A Rutishauser, Kyu Kwang Kim, et al.Journal of Experimental & Clinical Cancer Research : CR|August 21, 2024
Identification of circulating tumor cells captured by the FDA-cleared Parsortix<sup>®</sup> PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluationsMariacristina Ciccioli, Kyukwang Kim, Negar Khazan, et al.Plos One|December 2, 2024
The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancerKyukwang Kim, Negar Khazan, Jamie L McDowell, et al.Scientific Reports|February 26, 2020
Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell LinesKyu Kwang Kim, Rakesh K Singh, Negar Khazan, et al.Cancers|March 13, 2024
Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial CancerKyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner, et al.Obstetrics and Gynecology|September 8, 2022
Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic MassRichard George Moore, Negar Khazan, Madeline Ann Coulter, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 27, 2021
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 ExpressionRachael B Rowswell-Turner, Rakesh K Singh, Anze Urh, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AMLNegar Khazan, Cameron Wa Snyder, Chandhana Ravi, et al.Pageof 2